Cargando…

Plasma biomarkers predict Alzheimer’s disease before clinical onset in Chinese cohorts

Plasma amyloid-β (Aβ)42, phosphorylated tau (p-tau)181, and neurofilament light chain (NfL) are promising biomarkers of Alzheimer’s disease (AD). However, whether these biomarkers can predict AD in Chinese populations is yet to be fully explored. We therefore tested the performance of these plasma b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Huimin, Pang, Yana, Fu, Xiaofeng, Ren, Ziye, Jia, Longfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597998/ https://www.ncbi.nlm.nih.gov/pubmed/37875471 http://dx.doi.org/10.1038/s41467-023-42596-6

Ejemplares similares

A circular RNA blood panel that differentiates Alzheimer’s disease from other dementia types
por: Ren, Ziye, et al.
Publicado: (2022)

Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer’s disease
por: Cai, Huimin, et al.
Publicado: (2022)

CSF biomarkers for early-onset Alzheimer's disease in Chinese population from PUMCH dementia cohort
por: Lei, Dan, et al.
Publicado: (2023)

Blood-Derived Plasma Protein Biomarkers for Alzheimer’s Disease in Han Chinese
por: Cheng, Zaohuo, et al.
Publicado: (2018)

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Jia, Longfei, et al.
Publicado: (2021)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease
por: Stevenson-Hoare, Joshua, et al.
Publicado: (2022)

Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer’s disease
por: Li, Wenwen, et al.
Publicado: (2023)

Clinical and genetic characteristics in a central-southern Chinese cohort of early-onset Alzheimer's disease
por: Liang, Zhihou, et al.
Publicado: (2023)

Inflammatory biomarkers in Alzheimer's disease plasma
por: Morgan, Angharad R., et al.
Publicado: (2019)

Before it is too late: professional responsibilities in late-onset Alzheimer’s research and pre-symptomatic prediction
por: Schicktanz, Silke, et al.
Publicado: (2014)

Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
por: Jia, Longfei, et al.
Publicado: (2020)

SORL1 gene, plasma biomarkers, and the risk of Alzheimer’s disease for the Han Chinese population in Taiwan
por: Chou, Cheng-Ta, et al.
Publicado: (2016)

Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese
por: Chang, Xiao-Long, et al.
Publicado: (2016)

Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
por: Ba, Maowen, et al.
Publicado: (2016)

Evaluation of Utilizing the Distinct Genes as Predictive Biomarkers in Late-Onset Alzheimer's Disease
por: Kenanoglu, Sercan, et al.
Publicado: (2022)

Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
por: Thambisetty, Madhav, et al.
Publicado: (2011)

Plasma Biomarkers of Alzheimer’s Disease in African Americans
por: Deniz, Kaancan, et al.
Publicado: (2021)

Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
por: Brickman, Adam M., et al.
Publicado: (2022)

A metabolite panel that differentiates Alzheimer's disease from other dementia types
por: Jia, Longfei, et al.
Publicado: (2021)

Genetic association of urokinase-type plasminogen activator gene rs2227564 site polymorphism with sporadic Alzheimer's disease in the Han Chinese population☆
por: Ji, Xuelian, et al.
Publicado: (2012)

Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study
por: Vrillon, Agathe, et al.
Publicado: (2022)

Predictive risk factors before the onset of familial rheumatoid arthritis: the Tatarstan cohort study
por: Arleevskaya, Marina I., et al.
Publicado: (2023)

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer’s Disease Multimodal Biomarker Discovery Cohort
por: Westwood, Sarah, et al.
Publicado: (2020)

The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease
por: Ritchie, Craig W, et al.
Publicado: (2012)

Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer’s disease dementia in Chinese individuals
por: Sun, Qingling, et al.
Publicado: (2022)

Gene mutations in a Han Chinese Alzheimer's disease cohort
por: Ma, Limin, et al.
Publicado: (2018)

Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
por: Wang, Huimin, et al.
Publicado: (2021)

APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease
por: Zhou, Qin, et al.
Publicado: (2014)

Alterations of plasma cytokine biomarkers for identifying age at onset of schizophrenia with neurological soft signs
por: Liu, Jia-Yun, et al.
Publicado: (2020)

The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
por: Simrén, Joel, et al.
Publicado: (2021)

Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
por: Prins, Samantha, et al.
Publicado: (2022)

Plasma biomarker profiles in autosomal dominant Alzheimer’s disease
por: Johansson, Charlotte, et al.
Publicado: (2023)

Preanalytical stability of plasma biomarkers for Alzheimer's disease pathology
por: Sunde, Anita L., et al.
Publicado: (2023)

Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV
por: Li, Xuantao, et al.
Publicado: (2023)

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
por: Contador, José, et al.
Publicado: (2021)

Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
por: Li, Qiaojun, et al.
Publicado: (2022)

The Genetic Variation of SORCS1 Is Associated with Late-Onset Alzheimer’s Disease in Chinese Han Population
por: Xu, Wei, et al.
Publicado: (2013)

Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease
por: Zhang, Fan, et al.
Publicado: (2022)

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h5d0inhhno1bhg4oo0jut0dsk6